SANA - Sana Biotechnology, Inc. -  [ ]

Ticker Details
Sana Biotechnology, Inc.
IPO Date: February 1, 2021
Sector: Healthcare
Industry: Biotech
Market Cap: $854.36M
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.33 | 4.27%
Avg Daily Range (30 D): $0.11 | 3.13%
Avg Daily Range (90 D): $0.12 | 3.37%
Institutional Daily Volume
Avg Daily Volume: 1.99M
Avg Daily Volume (30 D): 3.77M
Avg Daily Volume (90 D): 2.74M
Trade Size
Avg Trade Size (Sh.): 148
Avg Trade Size (Sh.) (30 D): 224
Avg Trade Size (Sh.) (90 D): 173
Institutional Trades
Total Institutional Trades: 1,533
Avg Institutional Trade: $1.82M
Avg Institutional Trade (30 D): $2.59M
Avg Institutional Trade (90 D): $1.7M
Avg Institutional Trade Volume: .27M
Avg Institutional Trades (Per Day): 1
Market Closing Trades
Avg Closing Trade: $1.89M
Avg Closing Trade (30 D): $.96M
Avg Closing Trade (90 D): $1.06M
Avg Closing Volume: 273.28K
 
News
Apr 17, 2026 @ 5:23 PM
Kailera Therapeutics Debut Marks Largest Biotech I...
Source: Vandana Singh
Apr 14, 2026 @ 9:12 AM
Stock Market Today: Dow Jones, S&P 500 Futures Ris...
Source: Rishabh Mishra
Dec 8, 2025 @ 2:00 PM
Sana Biotechnology Announces Publication in Nature...
Source: Sana Biotechnology
Oct 15, 2025 @ 4:15 PM
Sana Biotech Stock — The Next '100-Bagger'?...
Source: Erica Kollmann
Aug 27, 2025 @ 11:00 AM
Quell Therapeutics Establishes World-Class Scienti...
Source: Quell Therapeutics
Financials
  TTM Q1 2026 Q4 2025
Basic EPS $-.93 $-.17 $-.21
Diluted EPS $-.93 $-.17 $-.21
Revenue $M $M $M
Gross Profit
Net Income / Loss $-241.99M $-47.21M $-58.83M
Operating Income / Loss $-248.3M $-48.61M $-61.2M
Cost of Revenue
Net Cash Flow $-12.33M $11.93M $-31.49M
PE Ratio